Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Chi Sheng Pharma & Biotech Co., Ltd. (4111) Income Statement

Chi Sheng Pharma & Biotech Co., Ltd. Income Statement

Last quarter (Q2 2026), Chi Sheng Pharma & Biotech Co., Ltd.'s total revenue was NT$375.11M, an increase of 2.00% from the same quarter last year. In Q2, Chi Sheng Pharma & Biotech Co., Ltd.'s net income was NT$44.39M. See Chi Sheng Pharma & Biotech Co., Ltd.’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
NT$ 1.38BNT$ 1.17BNT$ 1.06BNT$ 1.14BNT$ 1.02B
NT$ 507.61MNT$ 397.18MNT$ 343.10MNT$ 422.51MNT$ 356.58M
NT$ 308.30MNT$ 298.24MNT$ 281.89MNT$ 268.68MNT$ 237.52M
Depreciation and AmortizationNT$ 72.45MNT$ 65.12MNT$ 61.96MNT$ 72.88MNT$ 79.08M
NT$ 271.75MNT$ 204.56MNT$ 150.75MNT$ 236.69MNT$ 211.94M
NT$ 199.30MNT$ 98.95MNT$ 61.21MNT$ 163.81MNT$ 132.87M
NT$ 7.50MNT$ 38.75MNT$ 26.12MNT$ -1.52MNT$ -1.10M
NT$ 206.80MNT$ 137.70MNT$ 87.33MNT$ 162.28MNT$ 131.78M
NT$ 164.28MNT$ 110.63MNT$ 68.67MNT$ 154.01MNT$ 80.75M
Per Share Metrics
Basic EPSNT$ 2.75NT$ 1.94NT$ 1.21NT$ 2.70NT$ 1.42
Diluted EPSNT$ 2.72NT$ 1.93NT$ 1.20NT$ 2.69NT$ 1.41
Weighted Average Shares Outstanding59.83M56.98M56.76M56.98M56.98M
Weighted Average Shares Outstanding (Diluted)60.44M57.29M57.22M57.31M57.28M

Currency in TWD

Chi Sheng Pharma & Biotech Co., Ltd. Earnings and Revenue History

0500M1B1.5B4 %8 %12 %16 %EarningsProfit Margin2019202020212022202320242025RevenueEarningsProfit Margin